NCT03347331View on ClinicalTrials.gov

[18F]-F13640 as a New Brain Radiopharmaceutical

EARLY_PHASE1CompletedINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

April 23, 2018

Primary Completion Date

April 23, 2021

Study Completion Date

December 2, 2021

Conditions
Neurological PathologyHealthy Subjects
Interventions
DRUG

[18F]F13640

"Radiotracer injection and PET scan acquisition of 90 min:~\*150 Mbq + 1 MBq/Kg of \[18F\]F13640 at t=0 min~Arterial Blood Sampling during the 90min acquisition"

DRUG

[18F]F13640

2 Radiotracer injections and PET scan acquisition of 90 min distant from 1 to 3 weeks: For each exam: 150 MBq + 1 MBq/kg of \[18F\]F13640 at t=0 min

Trial Locations (1)

Unknown

Hospices Civils de Lyon, Bron

All Listed Sponsors
lead

Hospices Civils de Lyon

OTHER

NCT03347331 - [18F]-F13640 as a New Brain Radiopharmaceutical | Biotech Hunter | Biotech Hunter